Moore Capital Management LP Makes New $5.95 Million Investment in The Cooper Companies, Inc. $COO

Moore Capital Management LP purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, HoldingsChannel reports. The fund purchased 83,031 shares of the medical device company’s stock, valued at approximately $5,954,000.

A number of other institutional investors have also modified their holdings of the company. Algert Global LLC purchased a new position in Cooper Companies in the second quarter worth $7,655,000. Heartland Advisors Inc. acquired a new position in shares of Cooper Companies during the fourth quarter worth $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of Cooper Companies by 6.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company’s stock valued at $34,224,000 after purchasing an additional 23,896 shares during the last quarter. Tocqueville Asset Management L.P. purchased a new stake in shares of Cooper Companies during the 2nd quarter valued at $1,502,000. Finally, Capital International Inc. CA boosted its position in shares of Cooper Companies by 22.9% in the 4th quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock worth $9,688,000 after purchasing an additional 22,054 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

NASDAQ COO opened at $71.17 on Monday. The company has a market cap of $13.88 billion, a price-to-earnings ratio of 60.31, a PEG ratio of 1.86 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock’s fifty day moving average price is $72.56 and its 200 day moving average price is $70.81. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on COO shares. Wells Fargo & Company restated a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Needham & Company LLC lowered their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Robert W. Baird dropped their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. Finally, The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a report on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $81.64.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.